Nice HIV Cohort Follow-Up

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort uses the NADIS computerized medical record to track outcomes of people living with HIV who come in for regular outpatient visits. It builds on historical HIV databases and collects data from patients during standard care visits. The aim is to understand long-term patterns in health, treatment, and outcomes without assigning any new interventions. Data are drawn from existing medical records and follow-up is based on standard clinical appointments.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Enrol consecutive patients with a scheduled visit in the outpatient clinic (regardless of CD4 cell count and ART status).

Exclusion Criteria:

\-

Where it's running

• CHU de Nice
  Nice, France Recruiting

Study contacts

• Study coordinator: Christian PRADIER, Pr
• Email: pradier.c@chu-nice.fr

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• ICVAX therapeutic DNA vaccine for people living with HIV in Hong Kong

  This trial tests whether the ICVAX DNA vaccine, given with three different delivery devices, is safe and boosts HIV-specific T-cell responses in adults on stable antiretroviral therapy.

  Recruiting Phase 1 Yicura Holding (HK) Limited · Shatin, New Territories · NCT07530198

• Adding lenacapavir to ART to try to shrink hidden HIV reservoirs

  This study will test whether giving lenacapavir in addition to a stable ART regimen can reduce hidden HIV reservoirs in adults who have had undetectable viral loads for at least three years.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06819176

• SUSTAIN 2: Sustained HIV treatment support after interruptions in care

  This trial will test whether a six-month adherence club model with multi-month ART dispensing and peer support helps adults with HIV who missed care or have a raised viral load stay on treatment and reach viral suppression over 24 months.

  Recruiting Brigham and Women's Hospital · Cape Town · NCT06554223

• Long-acting injectable treatment for HIV in Belgium

  This study is looking to see how well people with HIV feel about and respond to a long-acting injectable treatment they’ve received.

  Recruiting Belgian Research on AIDS and HIV Consortium · Brussels · NCT06424964

• Universal Test and Connect for HIV services in Cape Town emergency departments

  This project tests whether offering universal HIV testing and connection-to-care in two Cape Town emergency departments can find people with HIV or at high risk and link them to treatment or PrEP.

  Recruiting Johns Hopkins University · Cape Town, Western Cape · NCT06408142

• Evaluating a new HIV vaccine combination in healthy adults

  This study is testing a new combination of HIV vaccines in healthy adults to see if they are safe and can help the body build protection against the virus.

  Recruiting Phase 1 U.S. Army Medical Research and Development Command · Kampala · NCT06205056

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.